JYNT stock icon

The Joint Corp
JYNT

$13.77
1.29%
 

About: The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.

Employees: 794

0
Funds holding %
of 6,702 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

33% more capital invested

Capital invested by funds: $109M [Q4 2023] → $145M (+$35.6M) [Q1 2024]

27% more call options, than puts

Call options by funds: $626K | Put options by funds: $492K

0% more funds holding in top 10

Funds holding in top 10: 2 [Q4 2023] → 2 (+0) [Q1 2024]

2.06% less ownership

Funds ownership: 77.13% [Q4 2023] → 75.07% (-2.06%) [Q1 2024]

7% less funds holding

Funds holding: 89 [Q4 2023] → 83 (-6) [Q1 2024]

31% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 35

40% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 15

Research analyst outlook

2 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$16
16%
upside
Avg. target
$18
31%
upside
High target
$20
45%
upside

2 analyst ratings

positive
100%
neutral
0%
negative
0%
B. Riley Securities
Jeff Van Sinderen
45%upside
$20
Buy
Maintained
6 May 2024
Roth MKM
George Kelly
16%upside
$16
Buy
Reiterated
3 May 2024

Financial journalist opinion